品牌 | 目录号 | 产品名称 | 规格 | 说明书 | 目录价 |
R&D system | 3726/1 | GSK 429286 (1 MG) | 1 MG | 点击阅读 | ¥1580 |
R&D system | 3726/10 | GSK 429286 (10 MG) | 10 MG | 点击阅读 | ¥3740 |
R&D system | 3725/10 | KU 0063794 (10 MG) | 10 MG | 点击阅读 | ¥3590 |
R&D system | 3724/50 | PD 161570 (50 MG) | 50 MG | 点击阅读 | ¥14480 |
R&D system | 3724/10 | PD 161570 (10 MG) | 10 MG | 点击阅读 | ¥3440 |
R&D system | 3722/50 | Reversan (50 MG) | 50 MG | 点击阅读 | ¥12290 |
R&D system | 3722/10 | Reversan (10 MG) | 10 MG | 点击阅读 | ¥2930 |
R&D system | 3721/50 | SR 48692 (50 MG) | 50 MG | 点击阅读 | ¥15740 |
R&D system | 3721/10 | SR 48692 (10 MG) | 10 MG | 点击阅读 | ¥3740 |
R&D system | 3718/50 | AS 1949490 (50 MG) | 50 MG | 点击阅读 | ¥9440 |
R&D system | 3718/10 | AS 1949490 (10 MG) | 10 MG | 点击阅读 | ¥2240 |
R&D system | 3716/50 | Adaphostin (50 MG) | 50 MG | 点击阅读 | ¥8780 |
R&D system | 3716/10 | Adaphostin (10 MG) | 10 MG | 点击阅读 | ¥2090 |
R&D system | 3715/1 | Narciclasine (1 MG) | 1 MG | 点击阅读 | ¥2390 |
R&D system | 3714/50 | TCS PIM-1 4a (50 MG) | 50 MG | 点击阅读 | ¥6890 |
R&D system | 3714/10 | TCS PIM-1 4a (10 MG) | 10 MG | 点击阅读 | ¥1640 |
R&D system | 3713/50 | Cryptotanshinone (50 MG) | 50 MG | 点击阅读 | ¥8180 |
R&D system | 3713/10 | Cryptotanshinone (10 MG) | 10 MG | 点击阅读 | ¥1940 |
R&D system | 3712/50 | NU 7441 (50 MG) | 50 MG | 点击阅读 | ¥12290 |
R&D system | 3712/10 | NU 7441 (10 MG) | 10 MG | 点击阅读 | ¥2930 |
R&D system | 3710/10 | PRIMA-1MET (10 MG) | 10 MG | 点击阅读 | ¥2090 |
R&D system | 3709/50 | MDL 72527 (50 MG) | 50 MG | 点击阅读 | ¥9830 |
R&D system | 3709/10 | MDL 72527 (10 MG) | 10 MG | 点击阅读 | ¥2330 |
R&D system | 3708/1 | Scrambled 10Panx (1 MG) | 1 MG | 点击阅读 | ¥1430 |
R&D system | 3707/50 | VU 0361737 (50 MG) | 50 MG | 点击阅读 | ¥8180 |
R&D system | 3707/10 | VU 0361737 (10 MG) | 10 MG | 点击阅读 | ¥1940 |
R&D system | 3706/50 | FR 180204 (50 MG) | 50 MG | 点击阅读 | ¥15440 |
R&D system | 3706/10 | FR 180204 (10 MG) | 10 MG | 点击阅读 | ¥3680 |
R&D system | 3705/50 | Endoxifen (50 MG) | 50 MG | 点击阅读 | ¥12290 |
R&D system | 3705/10 | Endoxifen (10 MG) | 10 MG | 点击阅读 | ¥2930 |